On ECHEMI
Home > Drugs > Yunpeng Pharmaceutical Group Co., Ltd.
Yunpeng Pharmaceutical Group Co., Ltd.
  • Founded in:

    1998-09-15
  • Country:

    China China
  • Address:

    No. 19, Yunpeng Avenue, Pharmaceutical Industrial Park, Xiangfen County, Linfen City, Shanxi Province
  • Tax NO.:

    911410027136140375
  • Registered Funds:

    200 million yuan
  • Website:

  • Email:

Related Drugs
Oleanolic acid tablets
Each tablet of this product contains 20 mg of the main ingredient, oleanolic acid.
Name Description Content CAS NO. Registered Holders
Oleanolic acid

It has a certain protective effect on liver damage, can reduce elevated serum alanine aminotransferase, promote liver cell regeneration, and accelerate the repair of necrotic tissue.

More

It has a certain protective effect on liver damage, can reduce elevated serum alanine aminotransferase, promote liver cell regeneration, and accelerate the repair of necrotic tissue.

20mg 508-02-1 10
Piroxicam Tablets
The main ingredient of this product is piroxicam.
Name Description Content CAS NO. Registered Holders
Piroxicam

It is a non-steroidal anti-inflammatory drug with analgesic, anti-inflammatory and antipyretic effects. This product exerts its pharmacological effects by inhibiting cyclooxygenase, reducing the synthesis of prostaglandins in local tissues, inhibiting the chemotaxis of leukocytes and the release of lysosomal enzymes.

More

It is a non-steroidal anti-inflammatory drug with analgesic, anti-inflammatory and antipyretic effects. This product exerts its pharmacological effects by inhibiting cyclooxygenase, reducing the synthesis of prostaglandins in local tissues, inhibiting the chemotaxis of leukocytes and the release of lysosomal enzymes.

36322-90-4 33
Carbocisteine Tablets
The main ingredient of this product is carbocysteine. Its chemical name is: S-(carboxymethyl)-cysteine. Molecular formula: C5H9NO4S Molecular weight: 179.19
Name Description Content CAS NO. Registered Holders
S-Carboxymethyl-L-cysteine

This product is a mucus regulator, which mainly acts on the secretion of bronchial glands, increasing the secretion of low-viscosity salivary mucin and reducing the production of high-viscosity fucoxomucin, thereby reducing the viscosity of sputum and making it easier to cough up. It takes effect quickly after oral administration, and obvious therapeutic effects can be seen within 4 hours of taking it.

More

This product is a mucus regulator, which mainly acts on the secretion of bronchial glands, increasing the secretion of low-viscosity salivary mucin and reducing the production of high-viscosity fucoxomucin, thereby reducing the viscosity of sputum and making it easier to cough up. It takes effect quickly after oral administration, and obvious therapeutic effects can be seen within 4 hours of taking it.

2387-59-9 13
Levamisole Hydrochloride Tablets
The main ingredient of this product is: Levamisole hydrochloride. Its chemical name is: (S)-(-)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole hydrochloride.
Name Description Content CAS NO. Registered Holders
Levamisole hydrochloride

It selectively inhibits succinate dehydrogenase in the muscles of the worm, affects the anaerobic metabolism of the muscles of the worm, and reduces energy production; it depolarizes the nerves and muscles, causing continuous contraction of the muscles and paralysis; its cholinergic effect is beneficial to the excretion of the worm; it may inhibit the microtubule structure of the worm; it has immune regulation and immune excitation functions.

More

It selectively inhibits succinate dehydrogenase in the muscles of the worm, affects the anaerobic metabolism of the muscles of the worm, and reduces energy production; it depolarizes the nerves and muscles, causing continuous contraction of the muscles and paralysis; its cholinergic effect is beneficial to the excretion of the worm; it may inhibit the microtubule structure of the worm; it has immune regulation and immune excitation functions.

16595-80-5 7
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.